|
|
Dr. Hill has an extensive background in neuropsychology, including post-doctoral
fellowships at the University of Pennsylvania and Thomas Jefferson University. Published
work has focused on understanding cognitive deficits in schizophrenia using traditional
neuropsychological tests. Current studies are focused on cognitive treatment effects and
integrating neuropsychological/cognitive neuroscience approaches to evaluating pharmacological
agents. Methods from neuropsychological and neurophysiological perspectives are integrated
with translational models and functional magnetic resonance imaging to assess the cognitive
impact of pharmacological interventions. This work is critical to advancing future treatment
of schizophrenia toward reduction of neurocognitive deficits and improvements in quality of
life and daily living.
Departement of Psychiatry - Personal Webpage
|
|